Washington - The U.S. Drug Enforcement Administration in coordination with federal partners and the People’s Republic of China convened the Bilateral Drug Intelligence Working Group (BDIWG) in Colorado Springs February 10 to 12, 2026. This working group brought together law enforcement, prosecutors, customs, border security, public security, financial supervision, and...

WASHINGTON – Today, the U.S. Drug Enforcement Administration, with the cooperation of the U.S. Attorney’s Office for the Eastern District of New York, announced the seizure of more than 200 website domains tied to an India-based transnational criminal organization (TCO) working within the United States and allegedly responsible for at...

WASHINGTON – 2025 was a year of historic achievements for the U.S. Drug Enforcement Administration highlighted by significant drug seizures, the capture of high-profile targets, and the confirmation of DEA Administrator Terrance C. Cole. Appointed by President Donald Trump on February 11, 2025 and sworn in on July 23, 2025...

SAN FRANCISCO – For a third consecutive year, the U.S. Drug Enforcement Administration and NFL Alumni Health (NFLAH) are joining forces to raise awareness about the dangers of fentanyl and spreading a critical message: One Pill Can Kill . Building on the success of the last two year, this collaboration...

The United States announced today that yesterday evening it took into custody 37 fugitives from Mexico facing a range of federal criminal charges around the country, including charges relating to narcoterrorism, providing material support to a foreign terrorist organization, firearms trafficking, human smuggling, money laundering, and various drug trafficking offenses...

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...

WASHINGTON – Federal and local law enforcement announced the arrests of 11 more alleged members of a fentanyl drug distribution network responsible for bringing hundreds of thousands of fake Oxycodone (M30) pills from California to D.C. Today's announcement was made by DEA Administrator Anne Milgram, U.S. Attorney Matthew M. Graves...

WASHINGTON – On Oct. 28, 2023, the community once again emptied their medicine cabinets to help dispose of old, unwanted, and expired medications. Nationwide, DEA and its law enforcement partners collected 599,897 pounds of unneeded medications at 4,675 collection sites nationwide. For more than a decade, DEA’s National Prescription Take...

WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...

WASHINGTON, DC – The Drug Enforcement Administration will host its 25th National Prescription Drug Take Back Day on Saturday, October 28, from 10 a.m. to 2 p.m. This event offers an easy, no-cost opportunity for the community to anonymously dispose of unneeded medications at nearly 5,000 local drop-off locations nationwide...